AORT - ARTIVION, INC.

QQQ $ 623.82 $ 4.38 (0.71 %)

DIA $ 473.95 $ 1.94 (0.41 %)

SPY $ 681.69 $ 4.15 (0.61 %)

TLT $ 89.46 $ 0.06 (0.07 %)

GLD $ 380.15 $ 2.40 (0.64 %)

Previous Close

$ 44.98

Open

$ 44.72

Bid

$ 43.90 x 1

Ask

$ 48.70 x 10

Day's Range

$ 43.90 - $ 45.53

52 Week Range

$ 21.97 - $ 47.69

Volume

479,310

Average Volume

Market Cap

2.13B

Beta (5Y Monthly)

$ 1.24

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-07-2025	09-30-2025	10-Q
2	08-08-2025	06-30-2025	10-Q
3	05-06-2025	03-31-2025	10-Q
4	02-28-2025	01-01-1970	10-K
5	11-08-2024	09-30-2024	10-Q
6	08-09-2024	06-30-2024	10-Q
7	05-07-2024	03-31-2024	10-Q
8	02-23-2024	12-31-2023	10-K
9	11-03-2023	09-30-2023	10-Q
10	08-04-2023	06-30-2023	10-Q
11	05-05-2023	03-31-2023	10-Q
12	02-23-2023	12-31-2022	10-K
13	11-04-2022	09-30-2022	10-Q
14	08-05-2022	06-30-2022	10-Q
15	05-06-2022	03-31-2022	10-Q
16	02-22-2022	12-31-2021	10-K
17	11-05-2021	09-30-2021	10-Q
18	07-30-2021	06-30-2021	10-Q
19	04-30-2021	03-31-2021	10-Q
20	02-23-2021	12-31-2020	10-K
21	11-05-2020	09-30-2020	10-Q
22	07-31-2020	06-30-2020	10-Q
23	05-01-2020	03-31-2020	10-Q
24	02-19-2020	12-31-2019	10-K
25	10-31-2019	09-30-2019	10-Q
26	07-31-2019	06-30-2019	10-Q
27	05-02-2019	03-31-2019	10-Q
28	02-26-2019	12-31-2018	10-K
29	11-01-2018	09-30-2018	10-Q
30	08-07-2018	06-30-2018	10-Q
31	05-04-2018	03-31-2018	10-Q
32	03-09-2018	12-31-2017	10-K
33	10-31-2017	09-30-2017	10-Q
34	07-25-2017	06-30-2017	10-Q
35	04-27-2017	03-31-2017	10-Q
36	02-16-2017	12-31-2016	10-K
37	10-27-2016	09-30-2016	10-Q
38	07-26-2016	06-30-2016	10-Q
39	04-29-2016	03-31-2016	10-Q
40	02-16-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Canaccord Genuity Maintains Buy on Artivio...
11/07/2025 21:35:53

Canaccord Genuity analyst William Plovanic maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $50 to...

Citizens Maintains Market Outperform on Ar...
11/07/2025 13:41:19

Citizens analyst Daniel Stauder maintains Artivion (NYSE:AORT) with a Market Outperform and raises the price target from $47...

Artivion Stock: A Deep Dive Into Analyst P...
11/07/2025 11:45:09

Needham Maintains Buy on Artivion, Raises ...
11/07/2025 10:01:10

Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $50 to $58.

Artivion Raises FY2025 Sales Guidance from...
11/06/2025 21:35:01

Artivion (NYSE:AORT) raises FY2025 sales outlook from $435.000 million-$443.000 million to $439.000 million-$445.000 million vs...

Artivion Q3 Adj. EPS $0.16, Sales $113.388...
11/06/2025 21:34:14

Artivion (NYSE:AORT) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.02 by 841.1...

Artivion Treats First Patient In ARTIZEN P...
11/06/2025 13:36:32

Artivion, Inc. (NYSE:AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the treat...

Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

Artivion To Present At 39th European Assoc...
10/13/2025 12:05:54

JMP Securities Maintains Market Outperform...
10/10/2025 13:01:29

JMP Securities analyst Daniel Stauder maintains Artivion (NYSE:AORT) with a Market Outperform and raises the price target fr...

Artivion To Acquire 1300 East Anderson Lan...
09/29/2025 20:48:42

On September 26, 2025, Artivion, Inc. (the "Company") entered into two Real Estate Purchase and Sale Contracts having s...

Stifel Maintains Buy on Artivion, Raises P...
09/29/2025 14:55:30

Stifel analyst Rick Wise maintains Artivion (NYSE: AORT) with a Buy and raises the price target from $40 to $46.

Beyond The Numbers: 7 Analysts Discuss Art...
09/29/2025 13:10:04

Across the recent three months, 7 analysts have shared their insights on Artivion (NYSE: AORT), expressing a variety of opinion...

Canaccord Genuity Maintains Buy on Artivio...
09/29/2025 12:13:21

Canaccord Genuity analyst William Plovanic maintains Artivion (NYSE: AORT) with a Buy and raises the price target from $41 t...

Needham Maintains Buy on Artivion, Raises ...
08/22/2025 11:11:09

Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $45 to $50.

Ladenburg Thalmann Downgrades Artivion to ...
08/13/2025 15:16:48

Ladenburg Thalmann analyst Jeff Cohen downgrades Artivion (NYSE:AORT) from Buy to Neutral and raises the price target from $...

Artivion Appoints Lance A. Berry, The Comp...
08/11/2025 17:30:11

-SEC Filing

Canaccord Genuity Maintains Buy on Artivio...
08/08/2025 21:02:39

Canaccord Genuity analyst William Plovanic maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $35 to...

Deep Dive Into Artivion Stock: Analyst Per...
08/08/2025 21:02:05

JMP Securities Maintains Market Outperform...
08/08/2025 15:28:16

JMP Securities analyst Daniel Stauder maintains Artivion (NYSE:AORT) with a Market Outperform and raises the price target fr...